Browse Studies — Arctuva

Phase 1

Innovative Therapy to Treat Women With Angina With Nonobstructive Coronary Artery Disease (ANOCA) and Coronary Microvascular Disease

The goal of this clinical trial is to that Sodium-glucose cotransporter 2 inhibitors treatment will improve Coronary Microvascular Disease with anginal symptom…

Angina Patients With Non-obstructive Coronary Artery DiseaseCoronary Microvascular DiseaseCoronary Microvascular Dysfunction (CMD)

Estimated

~$10 – $6,250

University of VirginiaNCT06600178

Assessment of Microcirculatory Function in Type 2 Myocardial Infarction

The purpose of this research is to find out if patients with Type 2 Myocardial Infarction (T2MI) without significant epicardial coronary artery disease (CAD) h…

Myocardial InfarctionCoronary Microvascular Disease

Estimated

~$10 – $750

Mayo ClinicNCT05793567

Comparative Evaluation of 18F-Flurpiridaz and 82Rb-Chloride PET Myocardial Perfusion Imaging: The FLARE (Flurpiridaz vs. Rubidium Evaluation) Trial

This study seeks to evaluate if the diagnostic performance of 18F-flurpiridaz positron emission tomography (PET) myocardial perfusion imaging (MPI), given the …

Coronary Artery DiseaseCoronary Microvascular Disease

Estimated

~$10 – $750

University of California, Los AngelesNCT07761728

Evaluation of Patients With Retinal Disorders Utilizing the XyCAM CRE Camera.

The primary objective of the XyCAM CRE Camera Study is to evaluate retinal blood flow, choroidal blood flow, and retinal structural features and their associat…

Microvascular DiseaseRetinal Disease

Estimated

~$10 – $1,125

Stuart Terry Eye AssociatesNCT07641738